Evidence map›Paper›PMID 21044778›Full record

ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2010

Dependence as a unifying construct in defining Alzheimer's disease severity.

Trent McLaughlin, Howard Feldman, Howard Fillit, Mary Sano, Frederick Schmitt, Paul Aisen, Christopher Leibman, Lisa Mucha, J Michael Ryan, Sean D Sullivan and 4 more

Open access · greenAbstract readReview
In one paragraph

Review in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 84 citations in OpenAlex.

  1. Cognitive rehabilitation for people with mild to moderate dementia.The Cochrane database of systematic reviews · 2023
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 3 countries.

Trent McLaughlinJanssen Alzheimer Immunotherapy Research & Development, South San Francisco, CA, USA.
Howard Feldman
Howard Fillit
Mary Sano
Frederick Schmitt
Paul Aisen
Christopher Leibman
Lisa Mucha
J Michael Ryan
Sean D Sullivan
D Eldon Spackman
Peter J Neumann
Joshua Cohen
Yaakov Stern
Icahn School of Medicine at Mount Sinai · USJanssen (United States) · USPfizer (United States) · USTufts Medical Center · USBristol-Myers Squibb (United States) · USColumbia University Irving Medical Center · USUniversity of California San Diego · USUniversity of Kentucky · USUniversity of Washington · USUniversity of York · GB

Funding

RECRUITMENT COREU19AG010483 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FELDMAN, HOWARD · 2013 to 2020
$80.6M
VESICULAR LOCALIZATION AND FUNCTION OF PRESENILIN 1 FRAGMENTP50AG005138 · NIA · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI GROSSMAN, HILLEL · 1985 to 2019
$37.9M
NIA NIH HHS P50 AG005138NIA NIH HHS U19 AG010483
6 · The paper itself

Abstract

This article reviews measures of Alzheimer's disease (AD) progression in relation to patient dependence and offers a unifying conceptual framework for dependence in AD. Clinicians typically characterize AD by symptomatic impairments in three domains: cognition, function, and behavior. From a patient's perspective, changes in these domains, individually and in concert, ultimately lead to increased dependence and loss of autonomy. Examples of dependence in AD range from a need for reminders (early AD) to requiring safety supervision and assistance with basic functions (late AD). Published literature has focused on the clinical domains as somewhat separate constructs and has given limited attention to the concept of patient dependence as a descriptor of AD progression. This article presents the concept of dependence on others for care needs as a potential method for translating the effect of changes in cognition, function, and behavior into a more holistic, transparent description of AD progression.

Indexed as

Dependency, PsychologicalDisability EvaluationSeverity of Illness IndexAgedAged, 80 and overAlzheimer DiseaseDisease ProgressionHumansIndependent LivingMiddle Aged

Identifiers

PMID21044778
PMCPMC3884683
OpenAlexW2162666828

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.